Miku Iwata

Miku Iwata

Auto-generated profile, based on publicly available information

Miku Iwata

Department of Hepato-Biliary-Pancreatic and Breast Surgery Toon City, Ehime, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2022 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
ASAkimasa Sakamoto
Akimasa Sakamoto
Ogawa KoheiOgawa Kohei
Ogawa Kohei
MIMiku Iwata
Miku Iwata
CIChihiro Ito
Chihiro Ito
MSMikiya Shine
Mikiya Shine
YTYasutsugu Takada
Yasutsugu Takada
Proinsulinoma is a subtype of insulinoma that is surgically curable, but localization can be difficult as these tumors are typically too small to be visualized by imaging. We report the case of a 53-year-old woman referred to our hospital with dizziness and headache. Her blood glucose level was 46 mg/dl and Whipple’s triad was present. Although her immunoreactive insulin level during hypoglycemia was in the normal range (5.0 μU/ml), the proinsulin level was elevated (408 pmol/l). Imaging examinations showed no evidence of pancreatic tumor. A preoperative selective arterial calcium injection (SACI) test showed excessive insulin secretion in the splenic artery region, which localized the proinsulinoma to the body or tail of the pancreas, and laparoscopic spleen-preserving distal pancreatectomy was performed. Intraoperative SACI test performed after tumor removal did not show excessive insulin secretion. The intraoperative SACI test appears to be useful for localization and for confirming complete resection of proinsulinoma.